Bosh sahifaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Yopilish kursi
163,64 $
Kunlik diapazon
159,65 $ - 163,00 $
Yillik diapazon
159,65 $ - 275,00 $
Bozor kapitalizatsiyasi
8,30 mlrd USD
Oʻrtacha hajm
802,66 ming
Narx/foyda
20,26
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 1,01 mlrd | -1,64% |
Joriy xarajat | 219,42 mln | 5,38% |
Sof foyda | 69,66 mln | -20,29% |
Sof foyda marjasi | 6,90 | -18,92% |
Har bir ulushga tushum | 2,59 | -4,78% |
EBITDA | 236,55 mln | -4,13% |
Amaldagi soliq stavkasi | 22,96% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 210,17 mln | 33,72% |
Jami aktivlari | 8,00 mlrd | 5,22% |
Jami passivlari | 4,18 mlrd | -1,88% |
Umumiy kapital | 3,83 mlrd | — |
Tarqatilgan aksiyalar | 51,14 mln | — |
Narxi/balansdagi bahosi | 2,21 | — |
Aktivlardan daromad | 4,65% | — |
Kapitaldan daromad | 5,62% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 69,66 mln | -20,29% |
Operatsiyalardan naqd pul | 251,79 mln | 22,56% |
Sarmoyadan naqd pul | -21,32 mln | 73,20% |
Moliyadan naqd pul | -207,54 mln | -27,43% |
Naqd pulning sof oʻzgarishi | 30,64 mln | 170,98% |
Boʻsh pul | 223,49 mln | 120,91% |
Haqida
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Tashkil etilgan
1947
Sayt
Xodimlar soni
21 100